Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism

Davor KustDepartment of Oncology and Nuclear medicine, University Hospital Center “Sestre milosrdnice”, University of Zagreb Medical School, CroatiaCorrespondence[email protected]

Ivan KruljacDepartment of Endocrinology, Diabetes and Metabolic Diseases “Mladen Sekso”, University Hospital Center “Sestre Milosrdnice”, University of Zagreb Medical School, Croatia

Ana Šverko PeternacDepartment of Radiology, University Hospital Center “Sestre Milosrdnice”, University of Zagreb Medical School, Croatia

Jelena OstojićDepartment of Pulmology, University Hospital Center “Sestre Milosrdnice”, University of Zagreb Medical School, Croatia

Marin PrpićDepartment of Oncology and Nuclear medicine, University Hospital Center “Sestre milosrdnice”, University of Zagreb Medical School, Croatia

Dubravka ČaržavecDepartment of Hematology, University Hospital Center “Sestre Milosrdnice”, University of Zagreb Medical School, Croatia

Petar GaćinaDepartment of Hematology, University Hospital Center “Sestre Milosrdnice”, University of Zagreb Medical School, Croatia

show all

References

Motzer RJ, Huston TE, Tomezak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009;27:3584–90.
PubMed Web of Science ®Google Scholar
Kollmannsberger C, Soulieres D, Wong R, Scalera A, Gaspo R, Bjarnason G. Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Can Urol Assoc J. 2007;1(2 Suppl):S41–S54.
PubMed Web of Science ®Google Scholar
Kust D, Prpić M, Murgić J, Jazvić M, Jakšić B, Krilić D, et al. Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy. Anticancer Res. 2014;34(6):3177–84.
PubMed Web of Science ®Google Scholar
Zare-Khormizi MR, Rahmanian M, Pourrajab F, Akbarnia S. Massive pericardial effusion and rhabdomyolysis secondary to untreated severe hypothyroidism: the first report. Acta Clin Belg. 2014;69(5):375–8.
PubMed Web of Science ®Google Scholar
Hataya Y, Akamizu T, Kanamoto N, Moriyama K, Shimatsu A, Nakao K. A case of subclinical hypothyroidism developing marked pleural effusions and peripheral edema with elevated vascular endothelial growth factor. Endocr J. 2007;54(4):577–84.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pleural and pericardial effusions combined with ascites in a patient with severe sunitinib-induced hypothyroidism

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date